Cash Flow Statement
Quarterly Data
The cash flow statement provides information about a company cash receipts and cash payments during an accounting period, showing how these cash flows link the ending cash balance to the beginning balance shown on the company balance sheet.
The cash flow statement consists of three parts: cash flows provided by (used in) operating activities, cash flows provided by (used in) investing activities, and cash flows provided by (used in) financing activities.
Paying user area
Try for free
Vertex Pharmaceuticals Inc. pages available for free this week:
- Common-Size Balance Sheet: Liabilities and Stockholders’ Equity
- Analysis of Profitability Ratios
- Analysis of Short-term (Operating) Activity Ratios
- Analysis of Long-term (Investment) Activity Ratios
- DuPont Analysis: Disaggregation of ROE, ROA, and Net Profit Margin
- Enterprise Value to FCFF (EV/FCFF)
- Present Value of Free Cash Flow to Equity (FCFE)
- Return on Assets (ROA) since 2005
- Current Ratio since 2005
- Debt to Equity since 2005
The data is hidden behind: . Unhide it.
Get full access to the entire website from $10.42/mo, or
get 1-month access to Vertex Pharmaceuticals Inc. for $24.99.
This is a one-time payment. There is no automatic renewal.
We accept:
Vertex Pharmaceuticals Inc., consolidated cash flow statement (quarterly data)
US$ in thousands
Based on: 10-Q (reporting date: 2025-09-30), 10-Q (reporting date: 2025-06-30), 10-Q (reporting date: 2025-03-31), 10-K (reporting date: 2024-12-31), 10-Q (reporting date: 2024-09-30), 10-Q (reporting date: 2024-06-30), 10-Q (reporting date: 2024-03-31), 10-K (reporting date: 2023-12-31), 10-Q (reporting date: 2023-09-30), 10-Q (reporting date: 2023-06-30), 10-Q (reporting date: 2023-03-31), 10-K (reporting date: 2022-12-31), 10-Q (reporting date: 2022-09-30), 10-Q (reporting date: 2022-06-30), 10-Q (reporting date: 2022-03-31), 10-K (reporting date: 2021-12-31), 10-Q (reporting date: 2021-09-30), 10-Q (reporting date: 2021-06-30), 10-Q (reporting date: 2021-03-31), 10-K (reporting date: 2020-12-31), 10-Q (reporting date: 2020-09-30), 10-Q (reporting date: 2020-06-30), 10-Q (reporting date: 2020-03-31).
- Net Income (Loss)
- The net income exhibited fluctuations throughout the periods. Initially, net income showed strong positive values, peaking at several points such as in September 2021 and December 2023. However, there was a notable significant loss in June 2024, indicating a substantial negative event or charge during that quarter. Net income rebounded in the following quarters, although volatility remained evident.
- Stock-based Compensation Expense
- Stock-based compensation expenses consistently remained sizeable and showed a general increasing trend over the periods, reaching the highest values towards the end of the timeline, particularly in the quarters of late 2023 and early 2024. This suggests a growing expense related to employee compensation or incentive plans.
- Depreciation and Amortization Expense
- This expense item gradually increased over time, with a marked jump in late 2023 and early 2024. The rise points to increased capital expenditure or amortization of intangible assets as the company expanded or invested in longer-term assets.
- Intangible Asset Impairment Charge
- An intangible asset impairment charge appears for the first time in June 2025, representing a significant non-cash charge that may have contributed to fluctuations in net income during that period, reflecting a reassessment of asset values.
- Deferred Income Taxes
- Deferred income taxes showed considerable volatility, with values swinging between positive and negative. Large negative values in certain periods, especially around mid-2022 through 2024, suggest recognition of tax benefits or timing differences, impacting the overall tax assets or liabilities.
- (Gains) Losses on Equity Securities
- Gains and losses from equity securities displayed a mixed pattern, with periods of significant gain followed by losses. Noteworthy large positive and negative values appear throughout, suggesting active investment management and volatile returns on equity holdings.
- Increase (Decrease) in Fair Value of Contingent Consideration
- This non-cash item demonstrated sporadic changes, with primarily small values except for a significant negative adjustment in December 2023, which may indicate a revision of contingent liabilities or acquisition-related adjustments.
- Other Non-Cash Items, Net
- Other non-cash items fluctuated irregularly, with large positive and negative swings, indicating variability in non-cash adjustments that could affect reported earnings but not cash flows, reflecting diverse accounting events across quarters.
- Working Capital Items (Accounts Receivable, Inventories, Prepaid Expenses, Accounts Payable, Accrued Expenses, Other Liabilities)
-
Accounts receivable fluctuated significantly, with large negative movements indicating changes in collections or revenue recognition practices, particularly negative in some quarters of 2022 to 2024.
Inventories showed a general increasing negative trend, especially in the later periods, suggesting an accumulation of stock or potential challenges in inventory turnover.
Prepaid expenses and other assets presented volatile movements including large negative shifts in some periods, reflecting timing differences or prepayments.
Accounts payable and accrued expenses showed alternating increases and decreases, signifying changes in payment timing or obligations. Accrued expenses notably swung between large positive and negative values, possibly indicating shifts in expense recognition or settlements.
Other liabilities had pronounced volatility with high positive spikes indicating possible new liabilities or adjustments, particularly in late 2022 and mid-2023.
- Operating Cash Flows
- Cash flows from operating activities generally showed strong positive inflows, with notable episodic declines including an extreme negative value in June 2024 corresponding with the reported net loss in the same period. Overall, operating cash flow remained robust, supporting core operations despite earnings volatility.
- Investing Activities
-
Investing cash flows were mostly negative, with consistent large purchases of available-for-sale debt securities, underscoring ongoing investment activities in debt markets.
Sales and maturities of these securities showed partial offsets but were generally less than purchases.
Significant capital expenditures on property and equipment were consistent, indicating steady investment in physical assets, with peaks in some quarters of 2023 and 2024.
There were isolated notable outflows related to acquisitions, as well as considerable variances in other investing activities, reflecting strategic growth or restructuring moves.
- Financing Activities
-
Net cash used in financing activities was predominantly negative, reflecting substantial repurchase of common stock and payments related to employee tax obligations on stock withholdings.
There were periods of stock issuances under benefit plans partially offsetting cash outflows, but overall the trend indicated net cash outflows related to shareholder returns and financing costs.
- Foreign Exchange Effect
- The effect of changes in exchange rates impacted cash variably, with several quarters showing meaningful positive or negative adjustments, which likely arose from the multinational presence and foreign currency exposure of assets and liabilities.
- Net Change in Cash Position
- The overall cash balance movements indicated positive net increases in most of the earlier periods through 2022, though large declines occurred in multiple quarters from late 2023 through 2024, in particular during the quarter with significant net income loss and impairment charges. Cash flows improved again toward the most recent periods, reflecting recovery efforts or operational resilience.